ZIVO Bioscience, Inc. (ZIVO)
ZIVO Bioscience, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Troy, MI, US. The stock last traded at $4.29, up 7.25% on the session, giving a market capitalisation of $16.7M. On trailing twelve-month figures it carries a trailing P/E of -2.51, a net margin of -5572.4%. Its beta of 0.11 implies it has historically moved less than the broad market.
ZIVO Bioscience, Inc. is a research and development firm that specializes in the creation and commercialization of natural bioactive compounds. These unique ingredients, derived from its proprietary algae cultures, are licensed and sold to manufacturers producing goods for animal health, human consumption, dietary supplements, and medical foods. The company operates at the intersection of biotechnology and agricultural technology, boasting a comprehensive intellectual property portfolio. This includes distinct algal and bacterial strains, advanced biologically active molecules and complexes, innovative production and cultivation techniques, and various inventions, some patented and others pending approval, all geared towards improving human and animal well-being. Its product applications are broad, addressing areas such as promoting gut health in poultry, combating bovine mastitis, improving joint function in canines, modulating the human immune system, providing algal biomass for direct human consumption, and offering biomass-based solutions for skin care and anti-aging. Founded originally as Health Enhancement Products, Inc., the company officially rebranded to ZIVO Bioscience, Inc. in October 2014. Its corporate operations are based in Bloomfield Hills, Michigan.
ZIVO Bioscience, Inc. is most often compared with the following Healthcare names: